Badal Shah
Founder & President
Bio:
Badal Shah, Founder & President of Neolytica- A QPharma Company, is a visionary leader whose strategic innovations in the pharmaceutical industry have marked him as a trailblazer. Arriving in the US at 22, his ambition led him to not only ascend to a pivotal role within QPharma but also to found Neolytica, AI-driven firm revolutionizing healthcare
analytics. Under his guidance, Neolytica has emerged as a key player, utilized by over thousands of pharmaceutical professionals globally, earning recognition as one of the "Top 100 Most Promising Companies in the USA Managed by Indians" by Silicon Magazine.
Neolytica's innovative methodologies in drug launch communication and field force optimization have contributed to the successful launch of over 145 drugs, including notable treatments for COVID-19. His contributions were celebrated with the "Top 100 Healthcare Leader of the Year" by Health 2.0 , "Entrepreneur of the Year" award by Forttuna
Awards and the "Global Young Indian of the Year" by AsiaOne Magazine, underscoring his significant impact on global healthcare.
The innovative solutions to measure the impact for medical affairs through a unique combination of AI + Medical experts, Omnichannel solutions to achieve effective medical communication has revolutionized the industry.
A revered figure, Shah's leadership extends beyond business to influential advisory roles in educational and professional bodies, emphasizing his dedication to fostering innovation and excellence in healthcare. His journey exemplifies the transformative power of visionary leadership and innovation in addressing complex healthcare challenges.